Vistra Has Progress, But Not Enough For A Buy (NYSE:VST)
· seekingalpha.com
Vistra (VST) stays a Hold: 2026 EBITDA/FCF guidance reaffirmed, but execution, regulatory and commodity risks persist.
Vistra ( VST ) right now looks pretty balanced in terms of risk and reward at the current price, so Hold still fits. That was my last call too. Before, I didn?...